Who to call at Alexion, and when
Fundz watches for the moments Alexion starts buying, and tells you who to reach.
- An alert the day Alexion raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alexion, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alexion. With Fundz connected, it knows.
Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years.
Contract Type
partnership
Description
The Wolves Foundation and Alexion have announced an extended partnership that will last for the next three years. Alexion will continue to support Wolves Disability FC and Wolves Wishes, enhancing community engagement and support for individuals affected by rare diseases.
Quick answer
Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026).
- What agreement did Alexion announce on October 29, 2026?
- The Wolves Foundation and Alexion have announced an extended partnership that will last for the next three years. Alexion will continue to support Wolves Disability FC and Wolves Wishes, enhancing community engagement and support for individuals affected by rare diseases.
- What does Alexion do?
- Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years,...
- Which similar companies announced agreements around the same time?
- BioMarin Pharmaceutical (October 29, 2026), Cognito Therapeutics (October 27, 2026), Georgiamune (October 25, 2026) and Teva Pharmaceutical Industries Ltd (November 3, 2026) also announced agreements within 45 days of Alexion.
Source: Fundz verified event record.
Other recent agreements in Medical and Therapeutics
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- BioMarin Enters Exclusive License Agreement With GC Biopharma and Hanmi Pharm for HM15421/GC1134A to Treat Fabry Disease. (October 29, 2026)
- Rhode Island Life Science Hub and Cognito Therapeutics launch partnership for Alzheimer's research. (October 27, 2026)
- Menarini and Georgiamune Enter $1.1 Billion License Agreement for Cancer Immunotherapy GIM-621. (October 25, 2026)
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402. (October 20, 2026)
Agreement Insights
What this usually meansAlexion signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.